Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Platelet-Rich Plasma Aids Healing After Tooth Extractions

By HospiMedica International staff writers
Posted on 06 May 2010
The use of platelet rich plasma (PRP) following tooth removal appears to speed healing and bone formation, according to a new study.

Researchers at Duquesne University (Pittsburgh, PA, USA) examined a simple method for obtaining a "Buffy Coat"-PRP (BC-PRP), and its effect on bone healing following the removal of bilateral mandibular third molars. More...
Subtraction digital radiography and computerized tomography (CT) scan analysis were used to track changes in the radiographic density at the PRP treated sites, in comparison to ipsilateral non-PRP treated sites. The patients returned after the operation for evaluations and digital radiographs at 3 days plus weeks 1, 2, 3, 4, 6, 8, 12, 16, 20, and 24. Observers checked them visually to evaluate the extraction site's tissue opening, bleeding, inflammation, facial edema, and pain.

The results showed that BC-PRP treated sites demonstrated early and significant increased radiographic density over baseline measurements following tooth removal, with the greatest benefit obtained during the initial 2-week postoperative healing period. During weeks 3 though 12, BC-PRP treatment resulted in significant increases in bone density compared to control; it required 6 weeks for control extraction sites to reach comparable bone density that PRP treated sites achieved at week one. Postoperative pain, bleeding, and numbness were not significantly affected by BC-PRP application. The study was published in the 2010 issue of the Journal of Oral Implantology.

"The PRP treatment had a positive effect on bone density immediately following tooth extraction,” said lead author James Rutkowski, D.M.D., Ph.D. "The immediate start of bone formation seen with PRP treatment is of clinical relevance because it is the initial 2 weeks following bone-manipulation oral surgery that are important.”

PRP is a concentrated (by centrifuge) source of autologous platelets, releasing via degranulation at least seven different growth factors that stimulate bone and soft tissue healing. PRP has become an increasingly popular clinical tool as an alternative source of growth factors for several types of medical treatments, including wound healing in surgery, tendonitis, cardiac care, cartilage regeneration, disc regeneration, and dental health. Additional dental applications of PRP include cosmetic periodontal surgery and the immediate restoration of dental implants.

Related Links:

Duquesne University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.